Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander J Robins

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Hypertension (Dallas, Tex. : 1979)|January 24, 2007
Multiple biomarkers and the risk of incident hypertensionThomas J Wang, Philimon Gona, Martin G Larson, et al.
The New England Journal of Medicine|December 22, 2006
Multiple biomarkers for the prediction of first major cardiovascular events and deathThomas J Wang, Philimon Gona, Martin G Larson, et al.
Atherosclerosis|January 13, 2009
Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart StudyRenate Schnabel, Josée Dupuis, Martin G Larson, et al.
Diabetes|October 17, 2009
Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart StudySusan Cheng, Joseph M Massaro, Caroline S Fox, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2011
Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studiesAbigail May Khan, Susan Cheng, Martin Magnusson, et al.
BMC Medical Genetics|October 16, 2007
Genome-wide association with select biomarker traits in the Framingham Heart StudyEmelia J Benjamin, Josée Dupuis, Martin G Larson, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Hypertension (Dallas, Tex. : 1979)|January 24, 2007
Multiple biomarkers and the risk of incident hypertensionThomas J Wang, Philimon Gona, Martin G Larson, et al.
The New England Journal of Medicine|December 22, 2006
Multiple biomarkers for the prediction of first major cardiovascular events and deathThomas J Wang, Philimon Gona, Martin G Larson, et al.
Atherosclerosis|January 13, 2009
Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart StudyRenate Schnabel, Josée Dupuis, Martin G Larson, et al.
Diabetes|October 17, 2009
Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart StudySusan Cheng, Joseph M Massaro, Caroline S Fox, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2011
Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studiesAbigail May Khan, Susan Cheng, Martin Magnusson, et al.
BMC Medical Genetics|October 16, 2007
Genome-wide association with select biomarker traits in the Framingham Heart StudyEmelia J Benjamin, Josée Dupuis, Martin G Larson, et al.
Pageof 5